Stockscreener 앱 받기
484.87
0.83%
3.78
전일 마감가:
$481.09
열려 있는:
$475.46
하루 거래량:
1.21M
Relative Volume:
0.73
시가총액:
$173.86B
수익:
$9.15B
순이익/손실:
$2.61B
주가수익비율:
67.62
EPS:
7.17
순현금흐름:
$1.99B
1주 성능:
-2.18%
1개월 성능:
-9.84%
6개월 성능:
-15.18%
1년 성능:
+7.57%
1일 변동 폭
$473.24
$485.11
1주일 범위
$473.24
$503.21
52주 변동 폭
$425.00
$616.00
인튜이티브 서지컬 Stock (ISRG) Company Profile
명칭
Intuitive Surgical Inc
전화
(408) 523-2100
주소
1020 KIFER ROAD, SUNNYVALE
ISRG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
485.01 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
175.79 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.45 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
280.02 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.14 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
인튜이티브 서지컬 Stock (ISRG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-23 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-06-09 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2025-06-05 | 업그레이드 | Erste Group | Hold → Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | 재확인 | Citigroup | Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-11-17 | 개시 | HSBC Securities | Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-19 | 재확인 | BTIG Research | Buy |
| 2023-04-19 | 재확인 | BofA Securities | Buy |
| 2023-04-19 | 재확인 | Citigroup | Buy |
| 2023-04-19 | 재확인 | Evercore ISI | In-line |
| 2023-04-19 | 재확인 | JP Morgan | Overweight |
| 2023-04-19 | 재확인 | Morgan Stanley | Equal-Weight |
| 2023-04-19 | 재확인 | RBC Capital Mkts | Outperform |
| 2023-04-19 | 재확인 | Raymond James | Outperform |
| 2023-04-19 | 재확인 | Stifel | Buy |
| 2023-04-19 | 재확인 | Truist | Buy |
| 2023-04-19 | 재확인 | Wells Fargo | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-23 | 개시 | William Blair | Outperform |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-13 | 개시 | Mizuho | Neutral |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-25 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | 다운그레이드 | Redburn | Buy → Neutral |
| 2022-01-21 | 재확인 | BTIG Research | Buy |
| 2022-01-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-21 | 재확인 | Deutsche Bank | Hold |
| 2022-01-21 | 재확인 | Evercore ISI | In-line |
| 2022-01-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-01-21 | 재확인 | Piper Sandler | Neutral |
| 2022-01-21 | 재확인 | Raymond James | Outperform |
| 2022-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2022-01-21 | 재확인 | Stifel | Buy |
| 2022-01-21 | 재확인 | UBS | Neutral |
| 2022-01-21 | 재확인 | Wells Fargo | Overweight |
| 2022-01-10 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-07-21 | 재확인 | BofA Securities | Neutral |
| 2021-07-21 | 재확인 | Citigroup | Buy |
| 2021-07-21 | 재확인 | JP Morgan | Overweight |
| 2021-07-21 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-07-21 | 재확인 | Piper Sandler | Neutral |
| 2021-07-21 | 재확인 | SVB Leerink | Mkt Perform |
| 2021-07-21 | 재확인 | Stifel | Buy |
| 2021-07-21 | 재확인 | UBS | Neutral |
| 2021-07-21 | 재확인 | Wells Fargo | Overweight |
| 2021-07-14 | 재확인 | Goldman | Buy |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-04-21 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2021-04-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | 개시 | Citigroup | Buy |
| 2020-12-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | 개시 | Argus | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-07-20 | 재확인 | Bernstein | Outperform |
| 2020-04-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
| 2020-04-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-04-01 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2020-01-27 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-12-12 | 재확인 | Wells Fargo | Outperform |
| 2019-11-21 | 개시 | Oppenheimer | Perform |
| 2019-07-19 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-22 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-02 | 개시 | Deutsche Bank | Buy |
| 2018-10-31 | 재확인 | Piper Jaffray | Overweight |
| 2018-10-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
모두보기
인튜이티브 서지컬 주식(ISRG)의 최신 뉴스
United States Surgical Robots Market Competition, Forecast - GlobeNewswire
United States Surgical Robots Market Competition, Forecast & Opportunities Report 2025-2030, with Medtronic, Intuitive Surgical, Stryker, Medrobotics, TransEnterix, Think Surgical, Accuray, and More - Yahoo Finance
Intuitive’s da Vinci 5 surgical system receives CE mark approval - Home | Digital Health
Intuitive Surgical's $1.26B Volume Spike Propels It to 97th Rank Amid Clinical Trial Updates and Market Momentum Plays - AInvest
Should I hold or sell Intuitive Surgical Inc. stock in 2025Expert Picks Signals To Watch Now - jammulinksnews.com
Robotic Surgery Co.'s Antitrust Appeal Backed At 9th Circ. - Law360
How volatile is Intuitive Surgical Inc. stock compared to the marketBreakout Stocks Signals Backed By Experts - jammulinksnews.com
LivsMed Debuts New Robotic System With Telesurgery Capabilities - Medical Product Outsourcing
What makes Intuitive Surgical Inc. stock price move sharplyAdvanced Screener Ideas For Every Investor - jammulinksnews.com
Intuitive Surgical (ISRG) Soared on Solid Financial Results - Insider Monkey
North America Microsurgery Robot Market Size & Growth, 2033 - Market Data Forecast
Intuitive Surgical Ranks 115th in $880M Trading Volume as Robotic Growth and Patent Approval Drive Short-Term Gains - AInvest
Intuitive Surgical’s New Study: A Closer Look at the Ion Endoluminal System - TipRanks
Lung Cancer Surgery Market to Reach USD 2.64 Billion by 2035, - openPR.com
Cathie Wood Goes Shopping: 3 Stocks She Just Bought - The Motley Fool
Jim Cramer on Intuitive Surgical: “I’m Inclined to Recommend the Stock” - Insider Monkey
5 Must-Read Analyst Questions From Intuitive Surgical’s Q2 Earnings Call - Yahoo Finance
Jim Cramer on Intuitive Surgical: "I’m Inclined to Recommend the Stock" - Yahoo Finance
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds - Investing.com
Intuitive Surgical’s SWOT analysis: robotic surgery leader faces tariff headwinds By Investing.com - Investing.com South Africa
One Buy-Rated Stock With An Unbreakable Moat That You Can’t Ignore - Barchart.com
HRH heralds arrival of robotic-assisted surgery - The Daily World
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
ISRG's Gross Margin Falls on Product Transition and Trade Pressures - Yahoo Finance
What are Intuitive Surgical Inc. company’s key revenue driversOutstanding capital appreciation - jammulinksnews.com
Intuitive Surgical's Insider Selling: A Signal or a Strategy in a Robotic Surge? - AInvest
Intuitive surgical gains momentum from procedure growth - MarketScreener
How strong is Intuitive Surgical Inc. company’s balance sheetAccess powerful market insights for free - jammulinksnews.com
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q2 2025 Earnings Call Transcript - MSN
Intuitive Surgical (ISRG) Shares Dip Despite Strong Q2 Performan - GuruFocus
12 out of 12 healthcare firms top revenue estimates this week: Earnings Scorecard - Seeking Alpha
Intuitive Surgical’s Strong Performance and Growth Potential Reinforce Buy Rating - TipRanks
Intuitive Surgical, Inc. (ISRG): “I Really Like” It, Says Jim Cramer - MSN
Intuitve surgical EVP Curet sells $2.2m in shares - Investing.com
Where Will Intuitive Surgical Be in 5 Years? - MSN
Daily Turnover | The turnover of Intuitive Surgical on 7/25 was $925.50 Million, Ranking 87 - AInvest
What drives Intuitive Surgical Inc. stock priceUnmatched market gains - PrintWeekIndia
ISRG Q2 Deep Dive: New Platform Drives Procedure Growth Amid Global Expansion - Yahoo Finance
Intuitive Surgical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Intuitive Surgical updates 2025 da Vinci procedure growth guidance to 15.5%-17% as da Vinci 5 launches expand - MSN
Intuitive Surgical’s Earnings Call: Growth Amid Challenges - The Globe and Mail
Intuitive Surgical Inc. Plummets to 70th in Trading Volume Despite Strong Financials and Strategic Partnerships - AInvest
What risks could impact Intuitive Surgical Inc. stock performanceOver 200% growth - jammulinksnews.com
FTC May Join Intuitive Surgical Antitrust Appeal - Law360
Senior DOJ Antitrust Officials Placed on Leave Amid Internal Turmoil - PYMNTS.com
Intuitive Surgical Crushes Q2 Expectations, So Why No Rally? - MSN
Robert W. Baird Keeps Their Buy Rating on Intuitive Surgical (ISRG) - The Globe and Mail
Intuitive Surgical Sees Early Wins With Da Vinci 5, Lifts FY25 Guidance As Tariff Impact Eases - insights.citeline.com
Decoding Intuitive Surgical Inc (ISRG): A Strategic SWOT Insight - GuruFocus
Intuitive Surgical Inc. (ISRG) Surges to 25th in Trading Volume with $2.339 Billion in Shares Exchanged Despite Stock Price Decline - AInvest
Intuitive Surgical Exceeds Expectations with Strong Q2 Performan - GuruFocus
인튜이티브 서지컬 (ISRG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.39%
2.89%
자본화:
|
볼륨(24시간):